Bimal Shantilal Doshi
About Bimal Shantilal Doshi
Data last updated:
Bimal Shantilal Doshi is a Director at Novo Excipients Private Limited (since 2011). The companies operate in Pharma. Novo Excipients Private Limited reported revenue of ₹104 Cr (FY 2025). Earlier, Bimal Shantilal Doshi was a Director at Sweta Pharma Pvt Ltd (2003–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novo Excipients Private Limited U24230MH2003PTC142463 | Director | 14 Jun 2011 | 2003 | ₹104 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sweta Pharma Pvt Ltd U24239MH1981PTC024656 | Director | 02 Sep 2003 | 1981 | ₹1.5 Lakh (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bimal Shantilal Doshi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gautam Chandrakumar Shah | 00271794 | Novo Excipients Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bimal Shantilal Doshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bimal Shantilal Doshi
Bimal Shantilal Doshi currently holds 1 directorship: Novo Excipients Private Limited (Director, since 14 Jun 2011, revenue ₹104 Cr (FY 2025)).
Bimal Shantilal Doshi was first appointed on 02 Sep 2003 as Director at Sweta Pharma Pvt Ltd. The most recent appointment on record is 14 Jun 2011 at Novo Excipients Private Limited.
Bimal Shantilal Doshi held 1 earlier board appointment: Sweta Pharma Pvt Ltd (Director, 02 Sep 2003 to 18 Oct 2024).
The current boards of Bimal Shantilal Doshi's companies include Gautam Chandrakumar Shah (Novo Excipients Private Limited).